In a surprising move with major implications for the vaping industry, the U.S. Food and Drug Administration (FDA) has granted marketing authorization to Juul Labs for its original JUUL device and Virginia Tobacco and Menthol pods. This approval comes after years of legal battles and shifting policy, making Juul only the second company to secure FDA approval for menthol-flavored vape products in the United States.

Juul Labs announced the FDA’s marketing authorization in a recent press release, confirming that the approved products include the original JUUL device and its Virginia Tobacco and Menthol refill pods in both 3% and 5% nicotine strengths. While the FDA itself has not released an official statement, this move marks a significant shift in regulatory tone. It positions Juul once again as a federally authorized player in the U.S. vaping market, particularly in the menthol vape space a segment with growing consumer demand and political scrutiny.

This decision follows the FDA's 2022 marketing denial order (MDO), which instructed retailers to pull Juul products from shelves nationwide. Juul responded with legal action, claiming that the FDA overlooked critical scientific data supporting its products' safety and efficacy. The courts granted a temporary stay, and within weeks, the FDA backed down placing the denial under review due to unresolved scientific questions. Now, with this new marketing approval, Juul reclaims a foothold in the market, joining NJOY as one of the only vape brands with menthol product authorization.

While this approval does not cover Juul’s newer age-verification-enabled device currently under FDA review, the reinstatement of the original JUUL device and pod lineup will likely spark renewed consumer interest. For vape retailers and customers alike especially those keeping a close eye on U.S. regulations—this development signals a possible easing of regulatory pressure on select closed pod systems. It also sets a precedent for future PMTA approvals, especially in the menthol vape category.

Conclusion:

The FDA’s marketing authorization for the JUUL device and select pods marks a dramatic turnaround in the agency’s regulatory approach. For Dragon Vape customers in USA and Canada, this decision is a strong indicator of shifting attitudes toward closed pod systems and menthol vape products. As industry regulations evolve, Dragon Vape remains committed to keeping you informed and stocked with the latest compliant and high-quality vaping options.

Source 1